New pill shows promise against tough lung cancer

NCT ID NCT07491497

Recruiting now Disease control Sponsor: TRIANA Biomedicines, Inc. Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jul 28, 2026 · Updated 4 times

Summary

This study tests a new daily pill called TRI-611 for adults with advanced ALK-positive non-small cell lung cancer (NSCLC) that has not responded to other treatments. The trial has two parts: first, finding the safest dose, and second, seeing how well it shrinks tumors in different groups based on prior therapy. About 160 participants will take the drug as long as it helps and is safe.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ALK POSITIVE NON-SMALL CELL LUNG CANCER are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

lung carcinoma non-small cell lung carcinoma

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

ALK POSITIVE NON-SMALL CELL LUNG CANCER ALK-POSITIVE LUNG CANCER ALK-POSITIVE NSCLC

Contacts and locations

Show contact details

Study contacts

Contact

Email: •••••@•••••

Locations

Dana Farber Cancer Center
RECRUITING

Boston, Massachusetts, 02215, United States

Contact Email: •••••@•••••
Duke University
RECRUITING

Durham, North Carolina, 27710-2000, United States
Massachusetts General Hospital
RECRUITING

Boston, Massachusetts, 02114, United States
Memorial Sloan-Kettering Cancer Center
RECRUITING

New York, New York, 10065, United States
NEXT Virginia
RECRUITING

Fairfax, Virginia, 22031, United States
Oncology Consultants Research (P1 Trials)
RECRUITING

Houston, Texas, 77030, United States
SCRI Oncology Partners
RECRUITING

Nashville, Tennessee, 37203, United States
START Mountain Region
RECRUITING

West Valley City, Utah, 84119, United States
Taylor Cancer Research Center
RECRUITING

Maumee, Ohio, 43537, United States
UCSF
RECRUITING

San Francisco, California, 94158, United States
University of Colorado Cancer Center
RECRUITING

Aurora, Colorado, 80045, United States
Washington University Medical Center
RECRUITING

St Louis, Missouri, 63130, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.